主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NAMS
#1222
NewAmsterdam Pharma Company N.V. Ordinary Shares
35.460
0
+5.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.00%
每月变动
+9.89%
6个月变化
-2.23%
年变化
-2.23%
前一天收盘价
33.770
0
Open
35.460
0
Bid
Ask
Low
35.460
0
High
35.460
0
交易量
59
市场
股票
医疗保健
NAMS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
92.39 M
109.82 M
112.27 M
112.63 M
113.39 M
114.98 M
—
Valuation ratios
Enterprise value
1.11 B
2.05 B
1.55 B
1.48 B
2.69 B
3.54 B
9.26 B
Price to earnings ratio
-7.38
-10.04
-11.13
-11.46
-14.15
-20.4
-57.13
Price to sales ratio
45.52
53.22
40.94
28.37
86.95
184.61
340.87
Price to cash flow ratio
-9.52
-15.29
-14.26
-15.52
-21.71
-28.11
-79.59
Price to book ratio
1.01
3.2
0.89
0.71
1.03
6.08
8.71
Enterprise value to EBITDA ratio
—
-10.6
—
—
-12.17
-14.24
—
Profitability ratios
Return on assets %
0.04
0.11
0.05
0.02
0.09
0.1
0.26
Return on equity %
0.04
0.12
0.05
0.02
0.1
0.11
0.28
Return on invested capital %
301.17
—
—
—
259.21
450.78
—
Gross margin %
100
63.69
-96.14
77.6
-816.95
-31.09 K
-31.92 K
Operating margin %
85.89
338.47
2 314.47
186.13
15.85 K
206.19 K
224.53 K
EBITDA margin %
—
-374.38
-2 508.87
-208.3
-16.74 K
-237.19 K
-256.65 K
Net margin %
57.18
721.71
1 327.3
90.7
20.69 K
234.13 K
256.24 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
10.61
8.08
19.98
21.08
12.57
7.88
61.51
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.02
0
0.02
0
0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.13
0.4
0.31
0.32
0.28
0.35
1.25
EBIT per share
—
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
EBITDA per share
—
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.46
8.18
6.96
6.23
5.91
5.37
24.48
Net current asset value per share
4.62
9.15
7.04
6.49
6.15
5.71
25.39
Tangible book value per share
3.99
8.02
6.69
6.56
6.11
5.77
25.13
Working capital per share
4.19
8.02
6.69
6.19
5.66
4.98
23.52
Book value per share
4
8.03
6.69
6.57
6.12
5.77
25.15
新闻
Cantor Fitzgerald重申NewAmsterdam Pharma股票评级为增持
Cantor Fitzgerald reiterates NewAmsterdam Pharma stock rating at Overweight
古根海姆因欧盟上市时间提前上调NewAmsterdam Pharma目标价
Guggenheim raises NewAmsterdam Pharma stock price target on EU launch timing
NewAmsterdam PharmaQ4每股收益及营收逊于预期
NewAmsterdam Pharma earnings missed by $0.23, revenue fell short of estimates
NewAmsterdam预计欧洲药品管理局将于2026年下半年就降胆固醇药物作出决定
NewAmsterdam expects EMA decision on cholesterol drug in second half 2026
Leerink Partners上调NewAmsterdam Pharma目标价至55美元
NewAmsterdam Pharma stock price target raised to $55 by Leerink Partners
派珀桑德勒看好2026年值得持有的商业生物科技股
Piper Sandler highlights commercial biotech names to own in 2026